Document:

EXHIBIT 10.2

 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY NOT BE SOLD OR OTHERWISE TRANSFERRED
IN THE ABSENCE OF SUCH REGISTRATION AND QUALIFICATION WITHOUT, EXCEPT AS OTHERWISE AGREED TO BY BORROWER, AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO BORROWER THAT SUCH REGISTRATION AND QUALIFICATION ARE NOT REQUIRED.

 

PROMISSORY NOTE

 

	$2,427,500.00	July 14, 2017

 

FOR VALUE RECEIVED, Capstone Therapeutics Corp.
(“Borrower”) hereby promises to pay to the order of BP Peptides, LLC (“Lender”), in lawful
money of the United States of America, the principal sum of Two Million Four Hundred Twenty-Seven Thousand Five Hundred Dollars
($2,427,500.00). Capitalized terms used but not defined herein shall have the respective meanings given to such terms in the Securities
Purchase, Loan and Security Agreement, dated as of July 14, 2017, between Borrower and Lender (the “Agreement”).
The principal of this Note will be payable on the Maturity Date.

 

Borrower also promises to pay interest on the
unpaid principal amount of the Loan, from the date of this Note until the payment in full thereof, at the rate per annum set forth
in Section 2(b)(i) or Section 2(b)(ii), as applicable, of the Agreement. Such interest will be payable on each date provided for
in such Section 2; provided, however, that interest (including Default Interest) on any principal portion which is
not paid when due will be payable on demand. All payments of principal of and interest on this Note shall be made in immediately
available funds.

 

All payments by Borrower of principal of and
interest on this Note will be made to Lender at its address referred to in Section 9(f) of the Agreement. If any payment becomes
due on a day other than a Business Day, the due date thereof shall be extended until the next succeeding Business Day, and interest
shall be payable at the applicable rate during such extension.

 

Borrower hereby authorizes Lender to endorse
on Schedule 1 (or continuation thereof) annexed to this Note the date and amount of the Loan made to Borrower and all payments
of principal amounts in respect of such Loan, which endorsements shall, absent manifest error, be conclusive evidence of the outstanding
principal amount of the Loan; provided, however, that the failure by Lender to make any such notation with respect
to the Loan or any payment thereof shall not limit or otherwise affect the obligations of Borrower under this Note.

 

The delay or failure to exercise any right hereunder
shall not waive such right. The undersigned hereby waives demand, presentment, protest, notice of dishonor or nonpayment, notice
of protest and all other demands and notices in connection with the delivery, acceptance, performance and enforcement of this Note,
any and all delays or lack of diligence in collection hereof and assents to each and every extension or postponement of the time
of payment or other indulgence.

 

     

     

    

Lender may, at any time, present this Note or
any sum payable hereunder to Borrower in satisfaction of any sum due or payable by Lender to Borrower for any reason whatsoever.

 

The payment and performance of Borrower’s
obligations under this Note are secured by a security interest in the Collateral, as defined and provided in the Agreement.

 

The occurrence of any one or more of the following
events shall constitute an Event of Default: (a) the failure to pay principal of this Note as and when due; (b) the failure to
pay when due any interest on this Note or any other payment required to be made to Lender under any Transaction Document within
five (5) Business Days following written notice to Borrower of non-payment; (c) any representation or warranty of Borrower contained
in the Transaction Documents shall prove to have been false in any material respect on or as of the date made; (d) the breach by
Borrower of, or failure of Borrower to perform or comply with, any covenant contained in the Transaction Documents, which breach
shall be continuing following thirty (30) days written notice of such breach; (e) a proceeding is filed or commenced against Borrower
for bankruptcy, reorganization, dissolution or liquidation which, in the case of an involuntary proceeding, is not dismissed or
discontinued within sixty (60) days, or Borrower voluntarily or involuntarily terminates or dissolves or is terminated or dissolved;
(f) the insolvency of, the appointment of a custodian, trustee, liquidator or receiver for any of the property of, an assignment
for the benefit of creditors by, or the filing of a petition under bankruptcy, insolvency or debtor’s relief law, or for
any readjustment of indebtedness, composition or extension by or against, Borrower; or (g) the liquidation, dissolution or winding
up of Borrower has been approved pursuant to its organizational or governing documents.

 

Borrower agrees that if an Event of Default
occurs under this Note, then Lender may declare the unpaid principal balance of this Note, together with interest and other amounts
owing in respect thereof, including but not limited to all fees and expenses provided for in the Agreement, to be immediately due
and payable without further notice or demand. In addition, Lender will have all of the rights and remedies provided in the Agreement
and by law. Borrower agrees to pay to Lender all expenses incurred by Lender, including reasonable attorneys’ fees, in enforcing
and collecting this Note.

 

In the event any one or more of the provisions
of this Note shall for any reason be held to be invalid, illegal or unenforceable, in whole or in part or in any respect, or in
the event that any one or more of the provisions of this Note operate to invalidate this Note, then and in either of those events,
such provision or provisions only shall be deemed null and void and shall not affect any other provision of this Note, and the
remaining provisions of this Note shall remain operative and in full force and effect and shall in no way be affected, prejudiced
or disturbed thereby.

 

Borrower further agrees to indemnify and hold
harmless Lender from and against any and all damages, liabilities, losses, costs and expenses (including, without limitation, reasonable
attorneys’ fees and expenses) which Lender may incur by reason of Borrower’s failure promptly to pay when due any indebtedness
evidenced by this Note.

 

This Note may be prepaid, in whole or in part,
by Borrower upon thirty (30) days prior written notice. This Note shall be paid without deduction by reason of any set-off, defense
or counterclaim of Borrower.

 

    	 	2	 

     

    

This Note shall be governed by and construed
in accordance with the laws of the State of Delaware, without giving any effect to principles of conflicts of law, and shall be
binding upon the successors and permitted assigns of Borrower and shall inure to the benefit of the successors and assigns of Lender.
Exclusive jurisdiction relating to this Note shall vest in the United States District Court for the District of Delaware located
in New Castle County, or, if jurisdiction in such court is not available, any state court located in New Castle County in the State
of Delaware.

 

	 	Capstone Therapeutics Corp.
	 	 
	 	 
	 	By:	
        /s/ Leslie M. Taeger

	 	 	Name:	Leslie M. Taeger
	 	 	Title:	Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

    	 	3	 

     

    

SCHEDULE 1

 

	
        Date
	
        Amount of Loan
	
        Amount of 

        Principal Repaid
	
        Unpaid 

        Principal Amount

	July 14, 2017	$2,427,500.00	 	 
	 	 	 	 
	 	 	 	 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4EXHIBIT 10.3

 

REGISTRATION RIGHTS AGREEMENT

 

Registration
Rights Agreement (this “Agreement”), dated as of July 14, 2017, by and between Capstone Therapeutics
Corp., a Delaware corporation located at 1275 West Washington Street, Suite 104, Tempe, Arizona 85281 (the “Company”),
and BP Peptides, LLC, a Delaware limited liability company located at 122 East 42nd Street, Suite 4305, New York, New
York 10168 (the “Investor”).

 

The parties hereto agree as follows:

 

1.                 
Definitions. Capitalized terms used but not defined herein shall have the respective meanings given to such terms
in the Securities Purchase, Loan and Security Agreement, dated as of the date hereof (the “Purchase and Loan Agreement”),
by and between the Company and the Investor. As used in this Agreement, the following capitalized terms shall have the following
meanings:

 

“Commission” means the Securities
and Exchange Commission.

 

“Common Stock” means the common
stock, par value $0.0005 per share, of the Company.

 

“Company Indemnitee(s)” shall
have the meaning assigned to such term in Section 7(b).

 

“Demand Registration” shall
have the meaning assigned to such term in Section 2(a).

 

“Exchange Act” means the Securities
Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Holder” means the Investor,
or any permitted assignee or successor of the Investor owning Registrable Securities. The terms “hold,” “held”
and “holding,” when used with respect to Registrable Securities shall mean owning Registrable Securities.

 

“Majority Holders” means one
or more Holders holding in the aggregate at least 50% of the Registrable Securities.

 

“Participants” means those
Holders participating as selling securityholders pursuant to a Registration Statement as contemplated by Section 2 or 3.

 

“Participant Indemnitee(s)”
shall have the meaning assigned to such term in Section 7(a).

 

    	1

     

    

 

“Person” means an individual,
partnership, corporation, limited liability company, business trust, unincorporated organization, joint venture, a government authority
or other entity of whatever nature.

 

“Prospectus” means the prospectus
included in any Registration Statement, as amended or supplemented by any prospectus supplement with respect to the terms of the
offering of any portion of the Registrable Securities covered by such Registration Statement, and all other amendments and supplements
to the prospectus, including any “free writing” prospectus and all material incorporated by reference in such prospectus.

 

“Register,” “registered,”
and “registration” refers to a registration effected by preparing and filing a Registration Statement or similar
document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such Registration Statement
or document.

 

“Registrable Securities” means
(a) any Common Shares held by a Holder and (b) any Common Stock issued with respect to, or in exchange for or in replacement
of, any Common Shares referred to in clause (a) above as a result of any stock split, stock dividend, recapitalization, reclassification,
exchange or similar event or otherwise; provided, however, that any Registrable Securities sold by a Person in a
transaction in which such Person’s rights under this Agreement are not assigned shall cease to be Registrable Securities
from and after the time of such sale and the transferee with respect to such securities shall cease to be a Holder pursuant hereto.
The number of Registrable Securities that are held by a Person or are outstanding shall be determined by the number of shares of
Common Stock that are Registrable Securities and either are held by such Person or outstanding (as applicable).

 

“Registration Statement” means
any registration statement of the Company which covers any of the Registrable Securities pursuant to any of the provisions of this
Agreement, including the Prospectus, amendments and supplements to such registration statement, including post-effective amendments,
all exhibits, and all material incorporated by reference in such registration statement.

 

“Required Holders” shall have
the meaning assigned to such term in Section 2(a).

 

“Securities Act” means the
Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

2.                 
Demand Registration.

 

(a)               
Request for Registration. Subject to the provisions of Section 2(b), at any time from and after the date hereof,
one or more Holders holding in the aggregate at least 25% of the outstanding Registrable Securities (the “Required Holders”)
may make a written request to the Company for registration under and in accordance with the provisions of the Securities Act of
the resale of Registrable Securities held by such Holder or Holders (a “Demand Registration”). The Company shall,
within five (5) Business Days after receipt of such request, give written notice (the “Notice”) of such request
to all other Holders known to the Company and will include in such registration all Registrable Securities with respect to which
the Company receives written requests for inclusion therein within twenty (20) Business Days after it gives the Notice to the applicable
Holder. Unless the Holder or Holders demanding the Demand Registration shall agree in writing, no other party, including the Company
(but excluding another Holder of Registrable Securities that requests inclusion in accordance with the preceding sentence) shall
be permitted to offer securities under any such Demand Registration. Notwithstanding the foregoing, if the Company shall furnish
to the Holder or Holders requesting a registration pursuant to this Section 2 a certificate signed by the Chief Executive Officer
of the Company stating that, in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental
to the Company and its shareholders for such registration statement to either become effective or remain effective for as long
as such registration statement would otherwise be required to remain effective, because (i) a material acquisition or disposition
by the Company, a Company reorganization or similar transaction is being negotiated, or (ii) such action would require premature
disclosure of material information that the Company has a bona fide business purpose for preserving as confidential, the Company
shall have the right to defer such filing for a period of not more than ninety (90) days; provided, however, that,
without the prior written consent of Investor, the Company may not utilize this right more than once in any twelve (12) month period.

 

    	2

     

    

 

(b)              
Number of Registrations. Notwithstanding any other provision of this Section 2, the Company shall not be required
to effect more than one (1) Demand Registrations regardless of the Person or Persons making the demand. The Company shall not be
deemed to have effected a Demand Registration unless and until such Demand Registration is declared effective by the Commission.
For purposes of this Section 2, a Registration Statement shall not be counted as a Demand Registration if, as a result of an exercise
of the underwriters’ cut-back provisions, less than 75% of the total number of Registrable Securities that the Holders have
requested to be included in such Registration Statement are so included.

 

(c)               
Priority on Demand Registrations. If the Demand Registration is an underwritten offering and the managing underwriter
or underwriters advise the Company in writing that in its or their opinion the number of Registrable Securities proposed to be
sold in such Demand Registration exceeds the number of securities which can be sold in such offering without a material adverse
effect on such offering, the Company will include in such registration only the number of securities which, in the opinion of such
underwriter or underwriters, can be sold, selected pro rata (based on the number of shares requested to be included) among
the Holders which have requested shares to be included in such Demand Registration pursuant to this Section 2; provided,
that any securities that the Required Holders have agreed may be included in such Demand Registration by the Company or any security
holder other than a Holder shall be cut back first.

 

(d)              
Selection of Underwriters and Counsel. If any Demand Registration is an underwritten offering, the Required Holders
will select the investment banker or bankers and manager or managers to administer the offering and one counsel to the sellers
of such Registrable Securities in such offering and the right of any Holder to registration shall be conditioned upon such Holder’s
participation in such underwriting; provided, however, that such investment bankers and managers be of nationally recognized
standing and reasonably acceptable to the Company. Subject to the provisions of Section 6, the Company shall pay the reasonable
fees and expenses of one such counsel to the sellers of such Registrable Securities incurred in connection with reviewing and otherwise
acting in connection with the Registration Statement relating to such underwritten public offering. If any Holder who has requested
inclusion of its Registrable Securities in such Registration Statement as provided above disapproves of the terms of the underwriting
or otherwise elects not to participate in such underwriting, such Holder shall provide written notice to the Company that the Holder
is not participating in such underwriting and that its Registrable Securities shall not be included in such Registration Statement;
provided, that an election by such Holder shall not affect the status of such Registration Statement as a Demand Registration.

 

    	3

     

    

 

(e)               
Underwriting Agreement. In connection with any Demand Registration under this Section 2, if so requested by the Required
Holders, the Company shall enter into an underwriting agreement with one or more underwriters selected in accordance with the provisions
of Section 2(a) above having terms and conditions customary for such agreements and reasonably acceptable to the Company.

 

3.                 
Piggyback Registration Rights.

 

(a)               
If the Company at any time or from time to time subsequent to the date hereof proposes to register the offer and sale of
any equity securities under the Securities Act either for its own account or the account of any selling security holders that are
not Holders (other than (i) a registration statement on Forms S-4 or S-8 or any successor or similar forms or (ii) a registration
on any form that does not permit secondary sales), it will give written notice to each of the Holders of its intention at least
ten (10) days in advance of the filing of any registration statement with respect thereto. Upon the written request of a Holder
given within fifteen (15) days after receipt of such notice, the Company, subject to Section 3(b), will use best efforts to include
in such registration, and in any underwriting involved therein, all the Registrable Securities included in such request (“Piggyback
Securities”). Notwithstanding the foregoing, the obligation of the Company to include Piggyback Securities in any registration
contemplated by this Section 3(a) shall cease and be terminated in the event the Company discontinues the applicable registration
at any time prior to the relevant effective date of registration in connection therewith.

 

(b)              
Underwritten Offerings.

 

(i)                
The right of any Holder to registration pursuant to this Section 3 shall be conditioned upon the participation by such Holder
in the underwriting arrangements specified by the Company in connection with such registration and the inclusion of the Registrable
Securities of such Holder in such underwriting to the extent provided herein. All Holders proposing to distribute their Registrable
Securities through such underwriting shall (together with the Company) enter into an underwriting agreement in customary form with
the managing underwriter or underwriters selected for such underwriting by the Company and take all other actions, and deliver
such opinions and certifications, as may be reasonably requested by such managing underwriter or underwriters.

 

    	4

     

    

 

(ii)              
Notwithstanding any other provision of this Section 3, if the managing underwriter or underwriters with respect to such
underwritten offering advise the Company in writing that marketing factors require a limitation of the number of shares of Common
Stock to be underwritten, the Company may limit the number of Registrable Securities to be included in such registration in accordance
with the opinion of such underwriter(s). The Company shall so advise all Holders distributing Registrable Securities through such
underwriting, and there shall be excluded from such registration and underwriting, to the extent necessary to satisfy such limitation,
first shares held by the Holders and, thereafter, to the extent necessary, shares that the Company wishes to register for its own
account. As among the Holders as a group, the number of Registrable Securities that may be included in the registration and underwriting
shall be allocated in proportion, as nearly as practicable, to the respective amounts of applicable Registrable Securities (determined
without regard to any requirement of a request to be included in such registration) held by all Holders at the time of filing the
Registration Statement. To facilitate the allocation of shares in accordance with the above provisions, the Company may round the
number of shares allocated to any Holder to the nearest 100 shares.

 

4.                 
Company Obligations. If and whenever the Company is required by the provisions of Section 2 of this Agreement to
effect a registration of Registrable Securities under the Securities Act, the Company shall promptly:

 

(a)               
Prepare and file with the Commission a Registration Statement on any form that may be utilized by the Company and that shall
permit the disposition of the Registrable Securities in accordance with the intended method or methods of disposition thereof,
and shall use its commercially reasonable efforts to cause such Registration Statement to become and remain continually effective
(subject to the delivery of a certificate of the Chief Executive Officer of the Company pursuant to Sections 2(a) and 3(a) hereof)
until the earlier of (i) such time as all of the Registrable Securities covered by such Registration Statement have been sold pursuant
to such Registration Statement or Rule 144 under the Securities Act, (ii) such time as all the Registrable Securities covered by
such Registration Statement are eligible to be resold pursuant to Rule 144 under the Securities Act without compliance with the
volume or manner of sale requirements thereof, or (iii) the termination of this Agreement pursuant to Section 9;

 

(b)              
Prepare and file with the Commission such amendments and supplements to such Registration Statement and the Prospectus contained
therein as may be necessary to keep such Registration Statement effective for the time periods contemplated by Section 4(a) and
such Registration Statement and Prospectus accurate and complete in all material respects during such period (including as may
be necessary to correct any statements or omissions in such Registration Statement, Prospectus or any other Prospectus then in
effect if any relevant event has occurred);

 

(c)               
Furnish to each Participant copies of the Registration Statement and Prospectus therein, or amendments or supplements thereto,
in such quantities as they may reasonably request;

 

(d)              
Use commercially reasonable efforts to register or qualify the Registrable Securities to be included in a Registration Statement
under the state securities or blue sky laws of such jurisdictions within the United States of America as such Participants may
reasonably request; provided, that the Company shall not be required to qualify to do business, subject itself to taxation
or consent to general service of process in any such state or jurisdiction;

 

    	5

     

    

 

(e)               
Notify the Participants in such registration, promptly after it shall receive notice thereof, of the date and time when
such Registration Statement and each post-effective amendment thereto has become effective or a supplement to any Prospectus forming
a part of such Registration Statement has been filed;

 

(f)               
To the extent permitted by law, notify the Participants in such registration promptly of any request by the Commission for
the amending or supplementing of such Registration Statement or Prospectus or for additional information;

 

(g)              
To the extent permitted by law, promptly notify the Participants in such registration of the filing of such amendments or
supplements to a Registration Statement or Prospectus as may be necessary to correct any statements or omissions if any event has
occurred as the result of which any such Registration Statement, Prospectus or any other Prospectus then in effect includes an
untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances then existing, not misleading;

 

(h)              
To the extent permitted by law, advise the Participants in such registration, promptly after it shall receive notice or
obtain knowledge thereof, of (i) the issuance of any stop order by the Commission suspending the effectiveness of such Registration
Statement or the initiation or threatening of any proceeding for that purpose and promptly use its best efforts to prevent the
issuance of any stop order or to obtain its withdrawal if such stop order should be issued, or (ii) any notification with respect
to the suspension of the qualification of the Registrable Securities for sale in any jurisdiction or the initiation or threatening
of any proceeding for such purpose;

 

(i)                
Otherwise use its best efforts to comply with all applicable rules and regulations of the Commission;

 

(j)                
Use its best efforts to obtain from its independent certified public accountants “cold comfort” letters in customary
form and at customary times and covering matters of the type customarily covered by cold comfort letters, as may be requested by
any managing underwriter of a registration;

 

(k)              
Use its best efforts to obtain from its counsel an opinion or opinions in customary form, as may be requested by any managing
underwriter of a registration;

 

(l)                
Provide a transfer agent and registrar (which may be the same entity) for such Registrable Securities not later than the
effective date of such Registration Statement;

 

(m)            
In the event of any underwritten public offering, perform its obligations under any underwriting agreement that it has entered
into with the managing underwriter;

 

    	6

     

    

 

(n)              
Cause all such Registrable Securities to be listed or accepted for quotation on any national securities exchange or automated
quotation system on which shares of the Common Stock are then listed or quoted; and

 

(o)              
Notify all Participants to such effect in the event that, in the judgment of the Company, it is advisable to suspend use
of a Prospectus included in a Registration Statement due to (i) pending material developments or other events that have not
yet been publicly disclosed and as to which the Company believes public disclosure would be materially detrimental to the Company,
or (ii) the Prospectus containing an untrue statement of a material fact or omitting to state any material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading.
Upon receipt of such notice, each such Participant shall immediately discontinue any sales of Registrable Securities pursuant to
such Registration Statement until such Participant has received copies of a supplemented or amended Prospectus or until such Participant
is advised in writing by the Company that the then current Prospectus may be used and has received copies of any amended Prospectus
or supplements to the Prospectus.

 

5.                 
Holder Obligations. Each Holder agrees as follows:

 

(a)               
Upon making a request pursuant to Section 2 or 3 hereof, to specify the number of Registrable Securities to be included
in a Registration Statement on its behalf and the intended method of distribution thereof.

 

(b)              
To the extent its Registrable Securities are to be included in any registration pursuant to this Agreement, to furnish to
the Company, in writing, such information regarding such Holder and the distribution of Registrable Securities proposed by such
Holder as the Company may from time to time reasonably request in writing and as shall be required in connection with such registration
or qualification of such Registrable Securities under any applicable securities law. Each Holder agrees to notify the Company as
promptly as practicable of any inaccuracy or change in information such Holder has previously furnished to the Company.

 

(c)               
Upon receipt of any notice from the Company of the happening of any event of a kind described in Section 4(g), (h) or (o),
to immediately discontinue the disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable
Securities until such Holder’s receipt of copies of any necessary amendment or supplement to such Registration Statement
or the Prospectus contained therein or its receipt of notice from the Company that no such amendment or supplement is required.

 

(d)              
To cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of any
Registration Statements in which Registrable Securities held by such Holder will be included.

 

(e)               
To comply with all applicable laws related to a registration, the filing of a Registration Statement and the offering and
sale of Registrable Securities and all applicable rules and regulations of governmental authorities in connection therewith (including
without limitation the Securities Act, the Exchange Act, applicable state securities laws and the rules and regulations promulgated
by applicable state authorities).

 

    	7

     

    

 

6.                 
Expenses of Registration.

 

(a)               
Subject to Section 6(b), the following expenses of the Company and the Holders in complying with their obligations pursuant
to this Agreement and in connection with each registration of Registrable Securities shall be borne by the Company:

 

(i)                
all registration, filing, qualification and listing fees of the Company;

 

(ii)              
fees and expenses of the Company’s compliance with all securities or blue sky laws (including fees and disbursements
of counsel for the Company in connection with blue sky qualifications of the Registrable Securities);

 

(iii)            
printing, messenger, telephone and delivery expenses for documents created by or to be delivered by the Company pursuant
to this Agreement;

 

(iv)            
fees and disbursements of counsel for the Company and its independent auditors; and

 

(v)              
with respect to any Demand Registrations, fees and disbursements of one counsel to the selling Holders up to a maximum of
$30,000.

 

(b)              
All underwriting discounts, selling and brokerage commissions or other compensation paid to underwriters or other agents
or brokers to effect the sale of Registrable Securities and other expenses in connection with a registration hereunder not required
to be paid by the Company pursuant to Section 6(a) shall be borne by the Holders on whose behalf such Registrable Securities are
included in a Registration Statement in proportion to the number of Registrable Securities included in such Registration Statement
on behalf of each such Holder.

 

(c)               
If the Required Holders request a Demand Registration and thereafter voluntarily withdraw such request, the Required Holders
shall bear the expenses of the Company referred to in Section 6(a) in connection with such request (and such request and any actions
by the Company pursuant thereto shall not be counted as one of the Demand Registrations to which the Holders are entitled under
this Agreement if the request to withdraw is received by the Company within ten (10) Business Days of the initial request, unless,
by notice to the Company, the Required Holders elect to have such request count as a Demand Registration to which the Holders are
entitled hereunder, in which case all of the Company’s expenses in connection with such request shall be borne by the Company).

 

7.                 
Indemnification and Contribution.

 

    	8

     

    

 

(a)               
Indemnification by the Company. Whenever a Registration Statement is filed hereunder, the Company will (except as
to matters covered by Section 7(b)) indemnify and hold harmless each Participant in the registration, each of their respective
officers, directors, members, managers, partners and employees, and each Person, if any, who controls any such Participant within
the meaning of the Securities Act or the Exchange Act (collectively, the “Participant Indemnitees” and, individually,
a “Participant Indemnitee”), against any and all losses, claims, damages, liabilities, costs and expenses (including
reasonable attorneys’ fees), joint or several, to which such Participant Indemnitees, or any of them, may become subject
under the Securities Act, the Exchange Act, state securities or blue sky laws or otherwise, insofar as such losses, claims, damages,
liabilities, cost or expenses (or actions in respect thereof) arise out of or are based upon (i) any untrue statement of any material
fact contained in such Registration Statement, or Prospectus contained therein, or any amendment or supplement thereto, or the
omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case
of any Prospectus, in light of the circumstances under which they were made) not misleading, except insofar as such losses, claims,
damages, liabilities, costs or expenses are caused by an untrue statement or omission or alleged untrue statement or omission that
is made in reliance upon and in conformity with information relating to any of the Holders furnished in writing to the Company
by any of the Holders, or (ii) any violation by the Company of the Securities Act, the Exchange Act or any state securities law,
or any rule or regulation thereunder, in connection with the performance of any of its obligations under this Agreement or with
the Registration Statement or the offering contemplated thereby, except where such violation is the direct result of an untrue
statement or omission or alleged untrue statement or omission that is made in reliance upon and in conformity with information
relating to any of the Holders furnished in writing to the Company by any of the Holders.

 

(b)              
Indemnification by Participants. Each Participant in such registration will, jointly and severally, indemnify and
hold harmless the Company, each of its directors, each of its officers, each Person, if any, who controls the Company within the
meaning of the Securities Act or the Exchange Act (collectively, the “Company Indemnitees” and, individually,
a “Company Indemnitee”), and each other Participant Indemnitee against any and all losses, claims, damage, liabilities,
costs and expenses (including reasonable attorneys’ fees), joint or several, to which any of the Company Indemnitees or the
other Participant Indemnitees may become subject under the Securities Act, the Exchange Act, state securities or Blue Sky laws
or otherwise, insofar as such losses, claims, damages, liabilities, costs or expenses (or actions in respect thereof) arise out
of or are based upon any untrue statement of any material fact contained in such Registration Statement, or Prospectus contained
therein, or any amendment or supplement thereto, or arise out of or are based upon the omission to state therein a material fact
required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, in light of the circumstances
under which they were made) not misleading, but only if, and to the extent that, such statement or omission is made in reliance
on and in conformity with written information furnished to the Company by such Participant for inclusion in such Registration Statement
or Prospectus.

 

    	9

     

    

 

(c)               
Indemnification Procedures. Reasonably promptly, and in each instance within thirty (30) days after receipt by a
Participant Indemnitee or a Company Indemnitee (collectively, “Indemnitees” and, individually, an “Indemnitee”)
of notice of the commencement of any action or commencement of a claim which may result in indemnity pursuant to Section 7(a)
or (b), such Indemnitee will, if a claim in respect thereof is to be made against the indemnifying party under Section 7(a) or
(b), notify the indemnifying party in writing of the commencement thereof, but any failure or delay in notifying the indemnifying
party will not relieve the indemnifying party from any liability which it may have to any Indemnitee hereunder unless the indemnifying
party is materially prejudiced by such delay, in which case such failure shall relieve such indemnifying party of any liability
to the indemnified parties under this Section 7 to the extent that such failure materially prejudices the indemnifying party’s
ability to defend such actions. The indemnifying party shall be entitled to participate in, and, to the extent that it may wish,
jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory
to such Indemnitee, after notice from the indemnifying party to such Indemnitee of its election to assume the defense thereof.
Following any such assumption of the defense, the indemnifying party shall not be liable to such Indemnitee for any legal or other
expenses subsequently incurred by such Indemnitee in connection with the defense thereof. The Indemnitee shall have the right
to employ one counsel per jurisdiction to represent such Indemnitee in any such action and to participate in the defense thereof,
but the fees and expenses of such counsel shall be at the expense of the Indemnitee unless, in the reasonable judgment of such
Indemnitee, it is advisable for such party to be represented by separate counsel because, in the reasonable discretion of separate
counsel, separate defenses are available, or because a conflict of interest exists between such Indemnitee and indemnifying party
in respect of such claim, or because the indemnifying party shall have failed promptly to assume the defense of such action and
to reasonably defend such action, and in any such limited event the reasonable fees and expenses of such separate counsel shall
be paid by the indemnifying party. Notwithstanding the foregoing, if the Company is an Indemnitee, the Company shall designate
the one counsel, and in all other circumstances, the one counsel shall be designated by a majority in interest based upon the
Registrable Securities of the Indemnitees. No indemnifying party may settle or compromise, or consent to the entry of any judgment
with respect to, any claim without the prior written consent of the Indemnitee (not unreasonably withheld, delayed or conditioned),
unless such settlement, compromise or judgment includes a full and unconditional release of such Indemnitee from any and all liability
in respect of such claim and involves solely the payment of monetary damages. No Indemnitee may settle or compromise, or consent
to the entry of any judgment with respect to, any claim without the prior written consent of the indemnifying party, not to be
unreasonably withheld, conditioned or delayed.

 

(d)              
Contribution. If for any reason the foregoing indemnity is held by a court of competent jurisdiction to be unavailable,
then the indemnifying party shall contribute to the amount paid or payable by the Indemnitee as a result of such losses, claims,
damages, liabilities, costs or expenses (i) in such proportion as is appropriate to reflect the relative benefits received by the
indemnifying party on the one hand and the Indemnitee on the other from the registration or (ii) if the allocation provided by
clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits
received by the indemnifying party on the one hand and the Indemnitee on the other but also the relative fault of the indemnifying
party and the Indemnitee as well as any other relevant equitable considerations. The relative fault shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to
state a material fact relates to information supplied by or on behalf of the indemnifying party or the Indemnitee and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The
Company and the Participants agree that it would not be just and equitable if contribution pursuant to this Section 7(d) were determined
by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations described
above. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any Person who was not guilty of such fraudulent misrepresentation. Notwithstanding anything to the contrary
contained herein, no Participant shall be required to contribute any amount in excess of the net proceeds actually received by
such Participant from its sale of Registrable Securities under the applicable Registration Statement and the Company shall be required
to contribute any amount in excess of such proceeds, except in the case of willful misconduct or fraud by such Holder.

 

    	10

     

    

 

(e)               
The provisions of this Section 7 shall survive the completion of any offering of Registrable Securities and the termination
of this Agreement. The indemnity and contribution agreements contained in this Section 7 are in addition to any liability that
an indemnifying party may have to an Indemnitee; provided, that in no event shall an Indemnitee be entitled to recover from
an indemnifying party more than once with respect to any specific loss, claim, damage, liability, cost or expense (including reasonable
attorneys’ fees) imposed on, sustained, incurred or suffered by, or asserted against the Indemnitee.

 

8.                 
Reports Under the Exchange Act. With a view to making available to the Holders the benefits of Rule 144 under the
Securities Act and any other rule or regulation of the Commission that may at any time permit a Holder to sell the Registrable
Securities to the public without registration, the Company agrees to, subject to Section 5(c) of the Purchase and Loan Agreement:

 

(i)                
make and keep current public information available, as those terms are understood and defined in Rule 144 under the Securities
Act, at all times after the date hereof;

 

(ii)              
file with the Commission in a timely manner all reports and other documents required of the Company under the Securities
Act and the Exchange Act; and

 

(iii)            
furnish to the Holders, so long as the Holder owns any Registrable Securities, forthwith upon request by the Majority Holders,
(i) a written statement as to its compliance with the reporting requirements of Rule 144 under the Securities Act and of the Exchange
Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by
the Company, and (iii) such other information in the possession of or reasonably obtainable by the Company as a Holder may reasonably
request in availing itself of any rule or regulation of the Commission which permits the Holder to sell Registrable Securities
without registration or pursuant to such form.

 

9.                 
Termination. This Agreement shall terminate and shall be of no further force or effect on the earlier of (i) the
fifth (5th) anniversary of the date hereof, or (ii) such date as Holders no longer hold collectively at least five percent (5%)
of the outstanding Common Stock of the Company.

 

    	11

     

    

 

10.             
Assignment.

 

(a)               
The rights to cause the Company to register Registrable Securities pursuant to this Agreement may be assigned, in whole
or in part, by the Investor (at Investor’s sole discretion and without the consent of the Company) to one or more transferees
(a “Subsequent Transferee”); provided, that to preserve and maintain such rights to cause the Company
to register Registrable Securities, any such Subsequent Transferee must (i) deliver to the Company a written instrument by
which such Subsequent Transferee agrees to be bound by the obligations imposed on Holders under this Agreement to the same extent
as if such Subsequent Transferee was a party hereto and (ii) deliver to the Company a written instrument setting forth full notice
and contact information for such Subsequent Transferee, including mailing address, email address, facsimile number and telephone
number (“Contact Information”); provided, further, that any further assignment of this Agreement
or the registration rights contained herein by such Subsequent Transferee to another transferee shall require the prior written
consent of the Company.

 

(b)              
In the event a Subsequent Transferee fails to provide the Company with the Contact Information contemplated by Section 10(a),
the Company shall have no obligation to provide such Subsequent Transferee with any notice, information, document or deliverable
to be mailed or delivered to Holders pursuant to this Agreement unless the Company otherwise has actual knowledge of the Subsequent
Transferee’s notice or contact information.

 

11.             
Delay of Registration. No Holder shall have any right to take any action to restrain, enjoin or otherwise delay any
registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Agreement.

 

12.             
Amendment and Modification; Waiver. This Agreement may be amended, modified or supplemented, and any provision herein
may be waived, in any respect only by written agreement by the Company and the Majority Holders; provided, however,
that no amendment or waiver that adversely affects a Holder in its capacity as a holder of Registrable Securities without similarly
affecting all Holders of Registrable Securities shall be effective without such adversely affected Holder’s approval. Any
amendment to this Agreement adopted in accordance with the provisions of this Section shall be binding on all of the parties to
this Agreement.

 

13.             
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of Delaware, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction
of the United States District Court for the District of Delaware located in New Castle County, or, if jurisdiction in such court
is not available, any state court located in New Castle County in the State of Delaware, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be
deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY
RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH
OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    	12

     

    

 

14.             
Invalidity of Provision. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid
or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable
shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability
of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the
parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

 

15.             
Notices. All notices, requests, demands, instructions or other documents or communications to be given under this
Agreement shall be given in accordance with the Purchase and Loan Agreement. With respect to any Holder that is not a party to
the Purchase and Loan Agreement, notice shall be given to such Holder in accordance with Section 9(f) of the Purchase and Loan
Agreement at such Holder’s address as delivered to the Company pursuant to Section 10(a). The Company shall have no
obligation to give notice to any address of a Holder other than as set forth in the Purchase and Loan Agreement (in the case of
Investor) or the notice delivered to the Company pursuant to Section 10(a).

 

16.             
Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and
the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party;
provided that a facsimile, electronic or .pdf signature shall be considered due execution and shall be binding upon the signatory
thereto with the same force and effect as if the signature were an original, not a facsimile, electronic or .pdf signature.

 

17.             
Headings. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the
interpretation of, this Agreement.

 

18.             
Entire Agreement. This Agreement, including any exhibits and schedules hereto and the documents and instruments referred
to herein and therein, embodies the entire agreement and understanding of the parties hereto in respect of the subject matter contained
herein. There are no restrictions, promises, representations, warranties, covenants or undertakings, other than those expressly
set forth or referred to herein. This Agreement supersedes all prior agreements and understandings among the parties with respect
to such subject matter.

 

    	13

     

    

 

19.             
Limitation on Subsequent Registration Rights. After the date of this Agreement, the Company shall not, without the
prior written consent of the Majority Holders, enter into any agreement with any holder or prospective holder of any securities
of the Company that would grant such holder registration rights senior to the registration rights of the Holders as provided in
this Agreement.

 

20.             
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and permitted assigns. The Investor may not assign this Agreement or any rights or obligations hereunder without the
prior written consent of the Company, except as contemplated by Section 10. The Company may not assign this Agreement or any rights
or obligations hereunder without the prior written consent of each Holder.

 

[Signatures begin on the following page.]

 

    	14

     

    

 

IN WITNESS WHEREOF,
this Agreement has been signed by each of the parties hereto as of the date first above written.

 

	 	 
	 	Capstone Therapeutics Corp.
	 	 
	 	 
	 	By:	
        /s/ Leslie M. Taeger

	 	 	Name:	Leslie M. Taeger
	 	 	Title:	Chief Financial Officer

 

 

	 	BP PEPTIDES, LLC
	 	 	 
	 	 	 
	 	By:	
        /s/ Matthew E. Lipman

	 	 	Name:	Matthew E. Lipman
	 	 	Title:	Manager and President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]